GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.

Lencioni R, Kudo M, Ye SL, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JF, de Guevara LL, Papandreou C, Takayama T, Yoon SK, Nakajima K, Lehr R, Heldner S, Sanyal AJ

Open source

DOI
10.1111/ijcp.12352
Published
2014 May
Container
International journal of clinical practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ijcp.12352,
  title = {GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.},
  author = {Lencioni R and Kudo M and Ye SL and Bronowicki JP and Chen XP and Dagher L and Furuse J and Geschwind JF and de Guevara LL and Papandreou C and Takayama T and Yoon SK and Nakajima K and Lehr R and Heldner S and Sanyal AJ},
  year = {2014},
  journal = {International journal of clinical practice},
  doi = {10.1111/ijcp.12352},
  url = {https://doi.org/10.1111/ijcp.12352}
}

RIS

TY  - JOUR
TI  - GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.
AU  - Lencioni R
AU  - Kudo M
AU  - Ye SL
AU  - Bronowicki JP
AU  - Chen XP
AU  - Dagher L
AU  - Furuse J
AU  - Geschwind JF
AU  - de Guevara LL
AU  - Papandreou C
AU  - Takayama T
AU  - Yoon SK
AU  - Nakajima K
AU  - Lehr R
AU  - Heldner S
AU  - Sanyal AJ
PY  - 2014
JO  - International journal of clinical practice
DO  - 10.1111/ijcp.12352
UR  - https://doi.org/10.1111/ijcp.12352
ER  - 

APA

R, L., M, K., SL, Y., JP, B., XP, C., L, D., J, F., JF, G., LL, D. G., C, P., T, T., SK, Y., K, N., R, L., S, H., & AJ, S. (2014). GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.. International journal of clinical practice. https://doi.org/10.1111/ijcp.12352

Source records